ARTPred B.V., founded in 2014, is a research-driven medtech company specializing in reproductive health. The company aims to fundamentally improve global fertility care by making its advanced technologies accessible to every fertility patient. Operating in the medtech sector, ARTPred focuses on increasing the success rates of In Vitro Fertilization (IVF) treatments. Currently, around 30% of all IVF treatments result in pregnancy, and ARTPred is committed to improving these rates by concentrating on the implantation phase. The company employs microbiome profiling and predictive algorithms to enhance the chances of successful implantation. ARTPred collaborates with strategic alliance partners to accelerate advancements and further increase IVF success rates. The business model revolves around offering cutting-edge fertility solutions to clinics and patients, generating revenue through the sale of its proprietary technologies and services.

Keywords: reproductive health, fertility care, IVF, microbiome profiling, predictive algorithms, medtech, implantation phase, strategic alliances, fertility solutions, advanced technologies.